Updates in Amblyopia Detection and Treatment
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2021: 12:00 AM
Ends On:
3/20/2022: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.75
Description:
Pediatric Optometrist, Ophthalmology and Visual Sciences
Washington University School of Medicine in St. Louis
Disclosures
Financial Relationships: No financial relationships to disclose
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Pediatric Early Bird Rounds, November 1, 2019, which is supported by St. Louis Children's Hospital.
Current Position: Assistant Professor, Pediatrics - Division of Hospitalist Medicine
Disclosures: No financial relationships to disclose.
Paula Murphy, RN, BSN, MBA
Current Position: Senior Physician Liaison
Disclosures: No financial relationships to disclose.
Faculty
Marisa O'Brien, MDPediatric Optometrist, Ophthalmology and Visual Sciences
Washington University School of Medicine in St. Louis
Disclosures
Financial Relationships: No financial relationships to disclose
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Pediatric Early Bird Rounds, November 1, 2019, which is supported by St. Louis Children's Hospital.
Planning Committee
Christine M. Hrach, MDCurrent Position: Assistant Professor, Pediatrics - Division of Hospitalist Medicine
Disclosures: No financial relationships to disclose.
Paula Murphy, RN, BSN, MBA
Current Position: Senior Physician Liaison
Disclosures: No financial relationships to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Describe Amblyopia
- Summarize vision screening practices
- Identify the importance of vision screenings
- LIst updates in amblyopia treatment
Additional Information:
Target Audience: This course is designed for Pediatricians, family and emergency physicians, physician assistants, nurse practitioners and other allied health professionals who encounter pediatric patients in a health care setting.
Publication Date: July 1, 2021
Expiration Date: March 20, 2022
Target Audience: This course is designed for Pediatricians, family and emergency physicians, physician assistants, nurse practitioners and other allied health professionals who encounter pediatric patients in a health care setting.
Publication Date: July 1, 2021
Expiration Date: March 20, 2022
Accreditation Information:
In support of improving patient care, this activity has been planned and implemented by St. Louis Children's Hospital and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
In support of improving patient care, this activity has been planned and implemented by St. Louis Children's Hospital and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit available for this activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hour.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1 ANCC contact hour.
References:
Chen AM, Cotter SA. The Amblyopia Treatment Studies: Implications for Clinical Practice. Adv Ophthalmol Optom. 2016 Aug: 1(1): 287-305. [PMC free article]- Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Opthalmology. 2006; 113:895-903 [PMC free article] [PubMed]
- Writing Committee for the Pediatric Eye Disease Investigator Group. Cotter S, Foster N, et al. Optical treatment for strabismic and combined strabismic-anisometropic amblyopia. Ophthalmology. 2012; 119:150-158 [PMC free article] [PubMed]
- Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regiments for treatment of moderate amblyopia in children. Arch Ophthalmol 2003; 121:603-611. [PubMed]
- Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children Ophthalmology. 2003: 110:2075-2087. [PubMed]
- Pediatric Eye Disease Investigator Group. A randomized trial of near versus distance activities while patching for amblyopia in children aged 3 to less than 7 years. Ophthalmology. 2008;115:2071-2078. [PMC free article] [PubMed]
- Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278. [PubMed]
- Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004;111:2076-2085. [PubMed]
- Peditaric Eye Disease Investigator Group. Pharmacologic plus optical penalization treatment for amblyopia: results of a randomized trial. Arch Ophthalmol. 2009;127:22-30. [PMC free article] [PubMed]
- Pediatric Eye Disease Investigator Group. Patching vs atropine to treat amblyopia in children aged 7 to 12 years: a randomized trial. Arch Ophthalmol. 2008;126:1634-1642. [PMC free article] [PubMed]
- Repka MX, Kraker RT, Beck RW, et al Treatment of severe amblyopia with weekend atropine: results from 2 randomized clinical trials. J AAPOS. 2009;13:258-263. [PMC free article] [PubMed]
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Category:
SLCH Series: CMEasy
